All In MedTech

Device Trial Radar · NCT05210283

CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer

CORRECT-MRD II: Second Colorectal Cancer Clinical Validation Study to Predict Recurrence Using a Circulating Tumor DNA Assay to Detect Minimal Residual Disease

Last checked: Nov 19, 2026Latest source record: Jan 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

1,017

Actual

Start

Dec 15, 2021

Primary completion

May 15, 2027

Study completion May 15, 2027

Sponsor

Lead sponsor
Exact Sciences CorporationNot on our public-company list
Sponsor type
Industry
Collaborators
NSABP Foundation Inc
First posted
Jan 27, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The CORRECT - MRD II study will prospectively enroll patients who have undergone complete surgical resection for stage II or III colorectal cancer. Maximum duration of participant participation is up to seven years from enrollment to study completion with up to five years of active follow up and up to two years of clinical (passive) follow up.

Conditions

  • Colorectal Cancer

Interventions

  • MRDDevice

    ctDNA MRD test

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To validate the association of circulating tumor DNA (ctDNA) with recurrence-free interval (RFI).Time frame: 7 years

Locations

32 sites in 2 countries. Site status is shown where the registry gives one.

  • Facey Medical Group - Mission Hills - Endoscopy Center & Gastroenterology

    Mission Hills, California

  • Torrance Memorial Hunt Cancer Institute

    Torrance, California

  • University of Florida Division of Hematology & Oncology

    Gainesville, Florida

29 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.